Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995767891> ?p ?o ?g. }
- W1995767891 endingPage "686" @default.
- W1995767891 startingPage "680" @default.
- W1995767891 abstract "We previously reported that DX-8951f, a novel water-soluble camptothecin analog, significantly inhibits the growth of various human and murine tumors in vitro and in vivo. The antitumor effects and topoisomerase I inhibitory activity of DX-8951f are stronger than those of other current camptothecin analogs. In this study, we established an SN-38-resistant cell line, PC-6/SN2-5, from the human oat cell carcinoma PC-6 cell line by a stepwise selection system, investigated the mechanism of resistance of this cell line and then compared the antitumor activity of camptothecin analogs against the cell line. PC-6/SN2-5 cells were resistant to SN-38 (32-fold) and SK&F104864 (topotecan; 14-fold), but barely resistant to CPT-11 (3-fold) and DX-8951f (2-fold). Topoisomerase I protein levels and topoisomerase I activities of parental cells were similar to those of resistant cells. Determination of the cellular drug concentration by either flow cytometric analysis or the high-performance liquid chromatography method confirmed that the cellular accumulation of SN-38 and topotecan was significantly reduced in PC-6/SN2-5 cells, whereas that of DX-8951f was only slightly reduced. Furthermore, DX-895lf stabilized the cleavable complex formations in intact PC-6/SN2-5 cells as well as in parental cells, but SN-38 and topotecan did not in the resistant cells. Our data suggest that PC-6/SN2-5 cells may have acquired resistance to camptothecin analogs by a decrease in intracellular drug accumulation and that DX-8951f may have the potency to overcome such a type of resistance mechanism induced by camptothecin compounds. Int. J. Cancer 72:680–686, 1997. © 1997 Wiley-Liss, Inc." @default.
- W1995767891 created "2016-06-24" @default.
- W1995767891 creator A5014560317 @default.
- W1995767891 creator A5021284597 @default.
- W1995767891 creator A5047487692 @default.
- W1995767891 creator A5051610127 @default.
- W1995767891 creator A5058598493 @default.
- W1995767891 creator A5085422425 @default.
- W1995767891 date "1997-08-07" @default.
- W1995767891 modified "2023-10-15" @default.
- W1995767891 title "DX-8951F, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant" @default.
- W1995767891 cites W1536538430 @default.
- W1995767891 cites W1897082568 @default.
- W1995767891 cites W1903533038 @default.
- W1995767891 cites W192877506 @default.
- W1995767891 cites W1952431753 @default.
- W1995767891 cites W1969762229 @default.
- W1995767891 cites W1980521536 @default.
- W1995767891 cites W1982075384 @default.
- W1995767891 cites W1999506028 @default.
- W1995767891 cites W2029330360 @default.
- W1995767891 cites W2048432325 @default.
- W1995767891 cites W2055625413 @default.
- W1995767891 cites W2066978733 @default.
- W1995767891 cites W2072652012 @default.
- W1995767891 cites W2078751203 @default.
- W1995767891 cites W2094864265 @default.
- W1995767891 cites W2110650955 @default.
- W1995767891 cites W2114918609 @default.
- W1995767891 cites W2328369261 @default.
- W1995767891 doi "https://doi.org/10.1002/(sici)1097-0215(19970807)72:4<680::aid-ijc21>3.0.co;2-e" @default.
- W1995767891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9259410" @default.
- W1995767891 hasPublicationYear "1997" @default.
- W1995767891 type Work @default.
- W1995767891 sameAs 1995767891 @default.
- W1995767891 citedByCount "62" @default.
- W1995767891 countsByYear W19957678912013 @default.
- W1995767891 countsByYear W19957678912015 @default.
- W1995767891 countsByYear W19957678912017 @default.
- W1995767891 countsByYear W19957678912020 @default.
- W1995767891 countsByYear W19957678912021 @default.
- W1995767891 countsByYear W19957678912022 @default.
- W1995767891 countsByYear W19957678912023 @default.
- W1995767891 crossrefType "journal-article" @default.
- W1995767891 hasAuthorship W1995767891A5014560317 @default.
- W1995767891 hasAuthorship W1995767891A5021284597 @default.
- W1995767891 hasAuthorship W1995767891A5047487692 @default.
- W1995767891 hasAuthorship W1995767891A5051610127 @default.
- W1995767891 hasAuthorship W1995767891A5058598493 @default.
- W1995767891 hasAuthorship W1995767891A5085422425 @default.
- W1995767891 hasConcept C121608353 @default.
- W1995767891 hasConcept C147897179 @default.
- W1995767891 hasConcept C1491633281 @default.
- W1995767891 hasConcept C153911025 @default.
- W1995767891 hasConcept C185592680 @default.
- W1995767891 hasConcept C202751555 @default.
- W1995767891 hasConcept C207001950 @default.
- W1995767891 hasConcept C2776694085 @default.
- W1995767891 hasConcept C2779682216 @default.
- W1995767891 hasConcept C2780259306 @default.
- W1995767891 hasConcept C2780508388 @default.
- W1995767891 hasConcept C2781209748 @default.
- W1995767891 hasConcept C526805850 @default.
- W1995767891 hasConcept C54355233 @default.
- W1995767891 hasConcept C55493867 @default.
- W1995767891 hasConcept C79879829 @default.
- W1995767891 hasConcept C81885089 @default.
- W1995767891 hasConcept C86803240 @default.
- W1995767891 hasConcept C98274493 @default.
- W1995767891 hasConceptScore W1995767891C121608353 @default.
- W1995767891 hasConceptScore W1995767891C147897179 @default.
- W1995767891 hasConceptScore W1995767891C1491633281 @default.
- W1995767891 hasConceptScore W1995767891C153911025 @default.
- W1995767891 hasConceptScore W1995767891C185592680 @default.
- W1995767891 hasConceptScore W1995767891C202751555 @default.
- W1995767891 hasConceptScore W1995767891C207001950 @default.
- W1995767891 hasConceptScore W1995767891C2776694085 @default.
- W1995767891 hasConceptScore W1995767891C2779682216 @default.
- W1995767891 hasConceptScore W1995767891C2780259306 @default.
- W1995767891 hasConceptScore W1995767891C2780508388 @default.
- W1995767891 hasConceptScore W1995767891C2781209748 @default.
- W1995767891 hasConceptScore W1995767891C526805850 @default.
- W1995767891 hasConceptScore W1995767891C54355233 @default.
- W1995767891 hasConceptScore W1995767891C55493867 @default.
- W1995767891 hasConceptScore W1995767891C79879829 @default.
- W1995767891 hasConceptScore W1995767891C81885089 @default.
- W1995767891 hasConceptScore W1995767891C86803240 @default.
- W1995767891 hasConceptScore W1995767891C98274493 @default.
- W1995767891 hasIssue "4" @default.
- W1995767891 hasLocation W19957678911 @default.
- W1995767891 hasLocation W19957678912 @default.
- W1995767891 hasOpenAccess W1995767891 @default.
- W1995767891 hasPrimaryLocation W19957678911 @default.
- W1995767891 hasRelatedWork W1692544167 @default.
- W1995767891 hasRelatedWork W1972477507 @default.
- W1995767891 hasRelatedWork W1988529521 @default.
- W1995767891 hasRelatedWork W2013571577 @default.
- W1995767891 hasRelatedWork W2022541271 @default.